New 'Ready-Made' cancer therapy trial seeks to tame tough blood cancers
Disease control
Recruiting now
This early-stage trial is testing the safety and early effectiveness of a new type of CAR T-cell therapy called azer-cel in adults whose B-cell blood cancers have returned or not responded to prior treatments. The therapy uses donor immune cells (allogeneic) engineered to target …
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC